echo ''; Clamorworld » In everyday life every one of us comes across various experiences, incidents which we either don’t share with anyone or share with family members and friends. Print media, electronic media and various medium shows the news, but its ends up showing one sided of the story. We never come to know the other side of story. With so much happening every day, every second across our neighborhood, society, and world it’s difficult for the news media to cover all the news. Many times we have felt wish we could share our voice, opinion, thoughts with the world. Many a times we have felt the frustration, anger and helplessness for not being able to do anything about an incident. Have you ever felt, for a good cause, you need support, but don’t know how to garner the support and attention. So, now you have an option ““. This is a platform to share everything you want to. A website 100% runs by the people for the people. The world is waiting to listen to your voice, the voice which has kept you suppressed so far. If you do not want to share the incident, event personally, please send it to us at, and we will share it on your behalf and assure to keep your name confidential. Let’s make this world a peaceful and a happy place to live. » Watch: Nihal Bitla, a boy with rare ‘Ageing Disease’ Progeria dies in Telangana

Watch: Nihal Bitla, a boy with rare ‘Ageing Disease’ Progeria dies in Telangana

The 15-year-old boy who was the Face of Progeria in India breathed his last on Monday night in Telangana.

While attending a family function, Nihal Bitla suffered severe dehydration before being admitted to a hospital on Monday evening.

The Boston-based Progeria Research Foundation announced Nihal’s death on his facebook page today.

Till date there is no cure for Progeria. It is a rare genetic disorder known to have a short life expectancy.

Nihal has won a legion of admirers for his ability to stay strong and optimistic while fighting a serious battle with this deadly disease.

Watch his inspirational story here.

Leave a reply